TKNO Q1 2021 Earnings — Alpha Teknova, Inc. Revenue & Financial Results | Market Cap Arena

TKNOAlpha Teknova, Inc.

$135M

Q1 2021 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$9M+48.5% YoY

Gross Profit

$5M55.4% margin

Operating Income

-$828,000-9.1% margin

Net Income

-$655,000-7.2% margin

EPS (Diluted)

$-0.03

QoQ Revenue Growth

-10.6%

Cash Flow

Operating Cash Flow

$2M

Free Cash Flow

-$1M

Stock-Based Comp.

$183,000

Balance Sheet

Total Assets

$76M

Total Liabilities

$60M

Stockholders' Equity

$16M

Cash & Equivalents

$14M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$9M	$6M	+48.5%
Gross Profit	$5M	$4M	+38.5%
Operating Income	-$828,000	$1M	-181.8%
Net Income	-$655,000	$948,000	-169.1%